|
|
Article: Cholesterol drug 'Vytorin' to be introduced
- Article from:
- Charleston Gazette
- Article date:
- July 19, 2004
- Author:
CopyrightCopyright 2004 Charleston Gazette. Provided by ProQuest LLC. (Hide copyright information)
|
NEW YORK - The fight for market share in the world's largest drug
category is about to intensify as a new cholesterol-lowering medicine
called Vytorin joins the pack that includes Lipitor, Zocor and
Crestor.
The introduction of Vytorin - expected to win Food and Drug
Administration approval later this month - is likely to ignite a
pricing and advertising battle.
Vytorin, a combination of two other cholesterol drugs, Zocor and
Zetia, has been shown in studies to lower cholesterol better than
market leader Lipitor. Zocor is from the class of drugs known as
statins, and lowers cholesterol by cutting its production in the
liver. Zetia, meanwhile, limits the absorption of cholesterol in the ...